These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6124392)

  • 1. Identification of sulfates in antipyrine metabolism in man, rat, and rabbit.
    Böttcher J; Bässmann H; Schüppel R
    Drug Metab Dispos; 1982; 10(1):90-1. PubMed ID: 6124392
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigations on antipyrine metabolism. II--Analysis of conjugated metabolites of antipyrine in rat and human urine by off-line combination of liquid chromatography and field desorption mass spectrometry.
    Lehmann WD; Böttcher J; Bässmann H; Schüppel R; Schiebel HM
    Biomed Mass Spectrom; 1982 Nov; 9(11):477-82. PubMed ID: 7159683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparative isolation and purification of urinary conjugates in antipyrine metabolism in man and rat.
    Böttcher J; Bässmann H; Schüppel R; Lehmann WD
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):226-33. PubMed ID: 7155204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of antipyrine by the epoxide-diol pathway in the rat, guinea pig and human.
    Stafford M; Kellermann G; Stillwell RN; Horning MG
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):593-606. PubMed ID: 4418208
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of p(4')-hydroxyantipyrine as a metabolite of antipyrine in man.
    Inaba T; Uchino H; Kalow W
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):3-8. PubMed ID: 7268206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and purification of three glucuronides of antipyrine. Proposal for an original analytical method for quantitation of sulpho- and glucuroconjugated metabolites.
    Palette C; Cordonnier P; Tillequin F; Koch M; Advenier C; Pays M
    Biomed Chromatogr; 1994; 8(2):77-84. PubMed ID: 8044026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4,4'-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man.
    Bässmann H; Böttcher J; Schüppel R
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(2):203-5. PubMed ID: 522906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of isopropylantipyrine metabolites in rat and man by using stable isotope tracer techniques.
    Goromaru T; Matsuura H; Furuta T; Baba S
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):3179-86. PubMed ID: 6518596
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose-dependent pharmacokinetics of antipyrine in the rat.
    Pollack GM; Li RC; Shen DD
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):69-81. PubMed ID: 6729251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct detection of antipyrine metabolites in rat urine by (13)C labeling and NMR spectroscopy.
    Akira K; Negishi E; Sakuma C; Hashimoto T
    Drug Metab Dispos; 1999 Nov; 27(11):1248-53. PubMed ID: 10534308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digitoxin metabolism by rat, mouse, and rabbit: NADPH requirement and spironolactone effect.
    Volp RF; Lage GL
    Res Commun Chem Pathol Pharmacol; 1982 Dec; 38(3):501-4. PubMed ID: 7163640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood and urine concentrations following intake of propyphenazone].
    Moosmayer A; Besserer K
    Beitr Gerichtl Med; 1982; 40():335-9. PubMed ID: 7165655
    [No Abstract]   [Full Text] [Related]  

  • 13. Phencyclidine N-oxide. Synthesis, decomposition and in vitro metabolism studies.
    Hallström G; Nguyen CH; Cho AK
    Acta Pharm Suec; 1983; 20(3):181-92. PubMed ID: 6637516
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of pirprofen in man, monkey, rat, and mouse.
    Egger H; Bartlett F; Yuan HP; Karliner J
    Drug Metab Dispos; 1982; 10(5):529-36. PubMed ID: 6128205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hydrolysis and acetolysis of free and conjugated osides].
    Bayard B; Montreuil J
    Arch Int Physiol Biochim; 1969 Aug; 77(3):564-5. PubMed ID: 4186389
    [No Abstract]   [Full Text] [Related]  

  • 16. Monthly variations in the clearance of antipyrine in the rat.
    Bélanger PM; Doré F; Labrecque G
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):53-65. PubMed ID: 6505390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolism of drugs. 58. Metabolism of butylaminoantipyrine].
    Yoshimura H; Shimeno H; Tsukamoto H
    Yakugaku Zasshi; 1968 Jan; 88(1):89-93. PubMed ID: 5692291
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biotransformation und pharmacokinetics of beta-methyl[1,1'-biphenyl]-4-propanenitrile (LU 20884) in rats. Studies on biotransformation].
    Neidlein R; Hofmann G
    Arzneimittelforschung; 1983; 33(7):920-5. PubMed ID: 6605150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spasmolytic activity of some 4-methylumbelliferone derivatives.
    Stacchino C; Spanò R; Pettiti A
    Boll Chim Farm; 1983 Mar; 122(3):158-60. PubMed ID: 6680324
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog.
    Cone EJ; Darwin WD; Buchwald WF; Gorodetzky CW
    Drug Metab Dispos; 1983; 11(5):446-50. PubMed ID: 6194952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.